Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 5Phase NA 4Phase 3 2

Status

Completed 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 12NIH 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 136Unspecified Adult Solid Tumor, Protocol Specific 122Leukemia, Lymphocytic, Chronic, B-Cell 119Lymphoma 103Breast Neoplasms 102Neoplasms 99Lymphoma, Follicular 98Burkitt Lymphoma 98Lymphoma, Large B-Cell, Diffuse 97Lymphoma, Non-Hodgkin 94Leukemia, Myeloid, Acute 89Lymphoma, Mantle-Cell 88Lymphoma, B-Cell, Marginal Zone 81Neoplasm Metastasis 80Lymphoma, Large-Cell, Immunoblastic 73Carcinoma, Non-Small-Cell Lung 68Melanoma 64Hodgkin Disease 64Lymphoma, T-Cell, Cutaneous 63Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 60Lymphoma, Large-Cell, Anaplastic 60Lung Neoplasms 60Prostatic Neoplasms 58Brain Neoplasms 58Astrocytoma 57Mycosis Fungoides 55Colonic Neoplasms 55Glioblastoma 54Sezary Syndrome 52Ovarian Neoplasms 52

Interventions

UAB 30 1Sulindac 1Specimen Handling 1Bexarotene 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × NIH × Carcinoma, Intraductal, Noninfiltrating × Clear all
NCT03317405 2026-05-04

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

National Cancer Institute (NCI)

Phase 1 Active not recruiting
32 enrolled 12 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT02876640 2024-06-18

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

National Cancer Institute (NCI)

Phase 1 Terminated
27 enrolled 21 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT03323658 2023-01-10

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled 12 charts
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT00637481 2016-12-29

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
66 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00245024 2013-05-03

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡